These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37815150)

  • 21. ASO Author Reflections: Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy.
    Verreck E; van Steenhoven J; van Dalen T
    Ann Surg Oncol; 2023 Sep; 30(9):5633-5634. PubMed ID: 37378845
    [No Abstract]   [Full Text] [Related]  

  • 22. Targeted axillary dissection with preoperative tattooing of biopsied positive axillary lymph nodes in breast cancer.
    Gatek J; Petru V; Kosac P; Ratajsky M; Duben J; Dudesek B; Jancik P; Zabojnikova M; Katrusak J; Opelova P; Podrazska L; Vazan P; Kudlova P; Holik P; Melichar B; Vrana D
    Neoplasma; 2020 Nov; 67(6):1329-1334. PubMed ID: 32749847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gamma-probe-guided resection of the sentinel lymph node in breast cancer.
    Crossin JA; Johnson AC; Stewart PB; Turner WW
    Am Surg; 1998 Jul; 64(7):666-8; discussion 669. PubMed ID: 9655279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Axillary lymph node treatment in breast cancer: an update.
    Williams PA; Suggs J; Mangana SH
    J Miss State Med Assoc; 2014 May; 55(5):145-7. PubMed ID: 25112128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
    Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
    JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ASO Author Reflections: Value of Sentinel Node Biopsy for Chest Wall Recurrence After Mastectomy.
    Vicini E; Fontana SKR; Leonardi MC; Veronesi P; Galimberti V
    Ann Surg Oncol; 2022 Mar; 29(3):1761-1762. PubMed ID: 34757548
    [No Abstract]   [Full Text] [Related]  

  • 28. Omitting completion axillary lymph node dissection after detection of sentinel node micrometastases in breast cancer: first results from the prospective SENOMIC trial.
    Andersson Y; Bergkvist L; Frisell J; de Boniface J
    Br J Surg; 2021 Sep; 108(9):1105-1111. PubMed ID: 34010418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.
    Veronesi U; Paganelli G; Viale G; Luini A; Zurrida S; Galimberti V; Intra M; Veronesi P; Robertson C; Maisonneuve P; Renne G; De Cicco C; De Lucia F; Gennari R
    N Engl J Med; 2003 Aug; 349(6):546-53. PubMed ID: 12904519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contemporary Axillary Management in cT1-2N0 Breast Cancer with One or Two Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database.
    Stafford AP; Hoskin TL; Day CN; Sanders SB; Boughey JC
    Ann Surg Oncol; 2022 Aug; 29(8):4740-4749. PubMed ID: 35451727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Axillary reverse mapping in patients undergoing axillary dissection -a short review of the literature.
    Noguchi M; Inokuchi M; Noguchi M; Morioka E; Kurita T
    Eur J Surg Oncol; 2020 Dec; 46(12):2218-2220. PubMed ID: 32912671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial experience with sentinel node biopsy in breast cancer at the National Cancer Center Hospital East.
    Imoto S; Hasebe T
    Jpn J Clin Oncol; 1999 Jan; 29(1):11-5. PubMed ID: 10073145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.
    Intra M; Trifirò G; Viale G; Rotmensz N; Gentilini OD; Soteldo J; Galimberti V; Veronesi P; Luini A; Paganelli G; Veronesi U
    Ann Surg Oncol; 2005 Nov; 12(11):895-9. PubMed ID: 16195833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
    Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
    JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Demonstration of the sentinel lymph node in axillary dissection for breast cancer].
    Salmon RJ; Fried D
    Presse Med; 1998 Mar; 27(11):509-12. PubMed ID: 9767960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial experience in a community hospital with sentinel lymph node mapping and biopsy for evaluation of axillary lymph node status in palpable invasive breast cancer.
    Morgan A; Howisey RL; Aldape HC; Patton RG; Rowbotham RK; Schmidt EK; Simrell CR
    J Surg Oncol; 1999 Sep; 72(1):24-30; discussion 30-1. PubMed ID: 10477872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-axillary breast cancer recurrences after sentinel node biopsy.
    van Rijk MC; Nieweg OE; Valdés Olmos RA; Rutgers EJ; Hoefnagel CA; Kroon BB
    J Surg Oncol; 2005 Dec; 92(4):292-8. PubMed ID: 16299804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Less is more: transmammary axillary lymph node evaluation: an initial clinical experience.
    Cocilovo C; Boolbol SK; Valdes E; Feldman S
    Am J Surg; 2006 Oct; 192(4):478-80. PubMed ID: 16978953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy.
    Tadros AB; Moo TA; Stempel M; Zabor EC; Khan AJ; Morrow M
    Breast Cancer Res Treat; 2020 Feb; 180(1):197-205. PubMed ID: 31938938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.